Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Sarah Milgrom

Concepts (359)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease
36
2025
138
10.400
 Why?
Radiotherapy, Intensity-Modulated
15
2024
142
3.170
 Why?
Positron Emission Tomography Computed Tomography
14
2023
98
2.870
 Why?
Radiotherapy
14
2025
201
2.320
 Why?
Fluorodeoxyglucose F18
7
2023
135
2.230
 Why?
Lymphoma
10
2025
208
2.230
 Why?
Tumor Burden
6
2024
309
2.220
 Why?
Antineoplastic Combined Chemotherapy Protocols
31
2025
1692
2.190
 Why?
Radiation Injuries
9
2025
145
1.990
 Why?
Central Nervous System Neoplasms
9
2021
156
1.800
 Why?
Radiopharmaceuticals
6
2023
178
1.700
 Why?
Radiotherapy Planning, Computer-Assisted
12
2024
130
1.660
 Why?
Lymphoma, Non-Hodgkin
6
2024
87
1.560
 Why?
Neoplasm Staging
30
2021
1389
1.440
 Why?
Lymphoma, Large B-Cell, Diffuse
8
2024
123
1.410
 Why?
Radiotherapy Dosage
16
2024
268
1.320
 Why?
Sarcoma
2
2023
188
1.270
 Why?
Neoplasm Recurrence, Local
13
2023
1079
1.250
 Why?
Salvage Therapy
11
2024
142
1.250
 Why?
Mediastinal Neoplasms
5
2021
45
1.150
 Why?
Endometrial Neoplasms
4
2014
201
1.130
 Why?
Hematopoietic Stem Cell Transplantation
7
2024
622
1.110
 Why?
Combined Modality Therapy
22
2024
1236
1.090
 Why?
Neoplasms
6
2025
2671
1.070
 Why?
Whole-Body Irradiation
2
2024
78
1.040
 Why?
Radiotherapy, Adjuvant
7
2024
220
1.030
 Why?
Prognosis
23
2025
4030
0.990
 Why?
Rhabdomyosarcoma
2
2024
72
0.960
 Why?
Positron-Emission Tomography
8
2024
294
0.940
 Why?
Sarcoma, Ewing
2
2024
97
0.930
 Why?
Humans
115
2025
137585
0.900
 Why?
Disease Progression
7
2024
2757
0.890
 Why?
Radiation
2
2020
24
0.840
 Why?
Craniopharyngioma
1
2024
74
0.830
 Why?
Radiation Exposure
1
2023
49
0.810
 Why?
Hematologic Neoplasms
1
2025
156
0.780
 Why?
Pituitary Neoplasms
1
2024
190
0.770
 Why?
Adenocarcinoma
3
2014
940
0.770
 Why?
Lymphoma, Follicular
5
2020
40
0.770
 Why?
Salivary Glands
2
2021
33
0.750
 Why?
Young Adult
34
2025
13209
0.750
 Why?
Smiling
1
2021
6
0.750
 Why?
Retrospective Studies
38
2024
15657
0.720
 Why?
Xerostomia
1
2021
17
0.720
 Why?
Tooth Abnormalities
1
2021
13
0.720
 Why?
Child
24
2025
21935
0.680
 Why?
Brachytherapy
1
2021
121
0.680
 Why?
Doxorubicin
13
2025
362
0.670
 Why?
Proton Therapy
1
2020
13
0.670
 Why?
Chemoradiotherapy
9
2021
225
0.660
 Why?
Face
1
2021
173
0.660
 Why?
Bleomycin
9
2025
248
0.660
 Why?
Vinblastine
9
2025
71
0.640
 Why?
Aged, 80 and over
22
2025
7635
0.630
 Why?
Intraocular Lymphoma
2
2016
3
0.630
 Why?
Aged
42
2025
23961
0.630
 Why?
Dacarbazine
9
2025
98
0.630
 Why?
Adult
53
2025
37929
0.630
 Why?
Infertility, Female
2
2025
108
0.620
 Why?
Middle Aged
50
2025
33479
0.610
 Why?
Lymphoma, B-Cell, Marginal Zone
4
2019
13
0.600
 Why?
Rectal Neoplasms
3
2016
149
0.590
 Why?
Adolescent
29
2025
21513
0.590
 Why?
Cerebellar Neoplasms
1
2020
152
0.580
 Why?
Medulloblastoma
1
2020
193
0.570
 Why?
Female
60
2025
73304
0.540
 Why?
Recurrence
9
2020
1060
0.540
 Why?
Leukemia, Biphenotypic, Acute
1
2016
3
0.520
 Why?
Leukemia, Myeloid, Acute
2
2023
630
0.520
 Why?
Meningeal Neoplasms
1
2018
100
0.510
 Why?
Cancer Survivors
1
2021
285
0.510
 Why?
Patient Satisfaction
1
2020
660
0.500
 Why?
Male
53
2025
67762
0.480
 Why?
Graft vs Host Disease
2
2024
252
0.480
 Why?
Head and Neck Neoplasms
1
2021
606
0.480
 Why?
Breast Neoplasms
5
2019
2253
0.470
 Why?
Treatment Outcome
25
2024
10811
0.470
 Why?
Eye Diseases
1
2016
87
0.470
 Why?
Brain Neoplasms
3
2023
1238
0.470
 Why?
Follow-Up Studies
16
2025
5131
0.450
 Why?
Survival Rate
12
2021
1972
0.450
 Why?
Disease-Free Survival
12
2020
686
0.430
 Why?
Consensus
4
2024
683
0.420
 Why?
Glycolysis
3
2023
321
0.420
 Why?
Endometrium
1
2013
58
0.410
 Why?
Peritoneal Cavity
1
2013
32
0.410
 Why?
Lymphoma, B-Cell
3
2021
106
0.400
 Why?
Digestive System Surgical Procedures
1
2014
106
0.400
 Why?
Palate, Hard
1
2012
6
0.400
 Why?
Stomach Neoplasms
3
2019
122
0.390
 Why?
Chemoradiotherapy, Adjuvant
3
2019
43
0.390
 Why?
Mastectomy, Simple
1
2012
1
0.390
 Why?
Neoadjuvant Therapy
2
2016
404
0.380
 Why?
Image Enhancement
1
2013
190
0.380
 Why?
Carcinoma, Lobular
1
2012
49
0.370
 Why?
Carcinoma, Ductal, Breast
1
2012
83
0.360
 Why?
Sentinel Lymph Node Biopsy
1
2012
115
0.360
 Why?
Adrenal Gland Neoplasms
1
2012
89
0.350
 Why?
Organs at Risk
3
2020
32
0.350
 Why?
Disease Management
6
2019
628
0.320
 Why?
Biopsy
6
2020
1129
0.320
 Why?
Radiotherapy, Image-Guided
3
2019
35
0.320
 Why?
Tomography, X-Ray Computed
7
2023
2691
0.320
 Why?
Cellulitis
1
2009
53
0.310
 Why?
Antineoplastic Agents
6
2025
2129
0.310
 Why?
Kaplan-Meier Estimate
7
2020
889
0.300
 Why?
Carcinoma, Squamous Cell
1
2014
683
0.290
 Why?
Lymphoma, Mantle-Cell
2
2019
21
0.290
 Why?
Lymphocytes
3
2020
397
0.290
 Why?
Survival Analysis
6
2020
1325
0.260
 Why?
Cardiotoxicity
2
2023
26
0.260
 Why?
Pregnancy Complications, Neoplastic
2
2017
52
0.260
 Why?
Multiple Myeloma
2
2020
252
0.250
 Why?
Patient Selection
2
2022
696
0.250
 Why?
Testicular Neoplasms
2
2018
110
0.250
 Why?
Child, Preschool
6
2025
11074
0.250
 Why?
Radiation Pneumonitis
2
2016
29
0.240
 Why?
Pelvic Neoplasms
1
2025
26
0.240
 Why?
Heart
3
2018
655
0.230
 Why?
Urodynamics
1
2025
44
0.230
 Why?
Urinary Tract
1
2025
51
0.230
 Why?
Lymph Node Excision
2
2019
171
0.230
 Why?
Antimetabolites, Antineoplastic
2
2017
94
0.230
 Why?
Risk Assessment
6
2023
3457
0.230
 Why?
Leukemia
2
2017
240
0.220
 Why?
Magnetic Resonance Imaging
4
2019
3566
0.220
 Why?
Transplantation, Haploidentical
1
2024
22
0.220
 Why?
Radiation Oncology
1
2025
82
0.220
 Why?
Lower Urinary Tract Symptoms
1
2025
60
0.220
 Why?
Central Nervous System
3
2021
258
0.220
 Why?
Mediastinum
3
2019
23
0.220
 Why?
Uterus
1
2025
215
0.210
 Why?
Virtual Reality
1
2025
61
0.210
 Why?
Lymphadenopathy
1
2023
10
0.210
 Why?
Risk Factors
5
2021
10388
0.210
 Why?
Cord Blood Stem Cell Transplantation
1
2024
99
0.210
 Why?
Lymphatic Metastasis
3
2014
352
0.200
 Why?
Transplantation Conditioning
1
2024
170
0.200
 Why?
Comprehension
1
2025
172
0.200
 Why?
Neoplasm Grading
4
2019
307
0.200
 Why?
Remission Induction
3
2018
288
0.200
 Why?
Protons
2
2020
89
0.190
 Why?
Brain Stem Neoplasms
1
2023
83
0.190
 Why?
Bone Neoplasms
1
2024
247
0.190
 Why?
Postoperative Complications
1
2014
2654
0.190
 Why?
Chemotherapy, Adjuvant
2
2013
389
0.190
 Why?
Radiometry
2
2019
50
0.190
 Why?
Gastric Mucosa
2
2019
55
0.190
 Why?
Cohort Studies
6
2024
5742
0.190
 Why?
Transplantation, Autologous
3
2018
238
0.180
 Why?
Mitogen-Activated Protein Kinase 7
1
2021
20
0.180
 Why?
Survivors
2
2023
493
0.180
 Why?
Multimodal Imaging
3
2017
113
0.180
 Why?
Poly(ADP-ribose) Polymerases
1
2021
98
0.180
 Why?
Radium
1
2020
3
0.180
 Why?
Imaging, Three-Dimensional
1
2025
580
0.170
 Why?
Breath Holding
2
2017
9
0.170
 Why?
Long Term Adverse Effects
1
2020
12
0.170
 Why?
Cranial Irradiation
2
2023
70
0.170
 Why?
Patient Education as Topic
1
2025
766
0.160
 Why?
Cardiology
1
2022
274
0.160
 Why?
Stem Cell Transplantation
2
2018
176
0.160
 Why?
Lung Neoplasms
2
2024
2526
0.160
 Why?
Clinical Trials as Topic
1
2024
1050
0.160
 Why?
Postoperative Care
2
2019
261
0.160
 Why?
Plasmacytoma
1
2019
16
0.160
 Why?
Skin Neoplasms
2
2018
855
0.160
 Why?
CD4-CD8 Ratio
1
2018
22
0.150
 Why?
Radiation Dosage
1
2020
179
0.150
 Why?
Mycosis Fungoides
1
2018
61
0.150
 Why?
Electrons
1
2018
83
0.150
 Why?
Methotrexate
2
2017
260
0.150
 Why?
Glioma
1
2023
395
0.150
 Why?
Breast Neoplasms, Male
1
2018
29
0.140
 Why?
Area Under Curve
1
2019
314
0.140
 Why?
Peritoneal Neoplasms
1
2019
93
0.140
 Why?
Radiotherapy Setup Errors
1
2017
3
0.140
 Why?
Autografts
1
2018
44
0.140
 Why?
Platelet Count
1
2017
86
0.140
 Why?
United States
3
2025
14841
0.140
 Why?
Hypothyroidism
1
2018
72
0.140
 Why?
Craniospinal Irradiation
1
2017
5
0.140
 Why?
Dendritic Cell Sarcoma, Follicular
1
2017
2
0.140
 Why?
Eye Neoplasms
1
2017
18
0.130
 Why?
Vincristine
4
2019
116
0.130
 Why?
Leukocyte Count
1
2017
329
0.130
 Why?
Caregivers
2
2025
877
0.130
 Why?
Uncertainty
1
2017
128
0.130
 Why?
Osteogenesis Imperfecta
2
2007
13
0.130
 Why?
Spinal Cord Diseases
1
2017
42
0.130
 Why?
Pentostatin
1
2016
1
0.130
 Why?
Axilla
2
2017
47
0.130
 Why?
Photopheresis
1
2016
9
0.130
 Why?
Neoplasm, Residual
1
2017
133
0.130
 Why?
Predictive Value of Tests
3
2022
2031
0.130
 Why?
Prospective Studies
5
2025
7604
0.130
 Why?
Methylprednisolone
1
2016
86
0.120
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
110
0.120
 Why?
Plasmablastic Lymphoma
1
2015
7
0.120
 Why?
Collagen Type I
2
2007
136
0.120
 Why?
Confidence Intervals
1
2016
329
0.120
 Why?
Antibiotics, Antineoplastic
1
2016
127
0.120
 Why?
Congenital Abnormalities
1
2016
92
0.120
 Why?
Abortion, Spontaneous
1
2016
105
0.120
 Why?
Fatal Outcome
1
2016
303
0.120
 Why?
Anxiety
1
2023
1035
0.120
 Why?
Hysterectomy
2
2013
129
0.120
 Why?
Drug Resistance, Neoplasm
2
2019
801
0.120
 Why?
Transplantation, Homologous
1
2016
416
0.120
 Why?
Proportional Hazards Models
4
2020
1266
0.120
 Why?
Tacrolimus
1
2016
199
0.120
 Why?
Coronary Artery Disease
1
2021
698
0.120
 Why?
Blood Platelets
1
2017
408
0.110
 Why?
Biomarkers
4
2021
4149
0.110
 Why?
Risk
1
2016
912
0.110
 Why?
Etoposide
3
2018
158
0.100
 Why?
Receptors, Progesterone
2
2014
350
0.100
 Why?
Age Factors
1
2021
3295
0.100
 Why?
Cyclophosphamide
3
2019
247
0.100
 Why?
Receptor, ErbB-2
2
2014
341
0.100
 Why?
Rituximab
3
2019
176
0.100
 Why?
Kidney Neoplasms
1
2018
403
0.100
 Why?
Carboplatin
1
2013
144
0.100
 Why?
Receptors, Estrogen
2
2014
436
0.100
 Why?
Spinal Cord
1
2015
370
0.100
 Why?
Pelvis
1
2013
102
0.100
 Why?
Anti-Inflammatory Agents
1
2016
496
0.100
 Why?
Carcinoma, Non-Small-Cell Lung
1
2021
1081
0.100
 Why?
Lung
2
2016
4060
0.100
 Why?
Fluorouracil
1
2013
208
0.100
 Why?
Radiotherapy, Conformal
1
2012
70
0.100
 Why?
Paclitaxel
1
2013
230
0.090
 Why?
Neutrophils
1
2017
1238
0.090
 Why?
Health Knowledge, Attitudes, Practice
1
2020
1329
0.090
 Why?
Immunoenzyme Techniques
1
2012
219
0.090
 Why?
Immunohistochemistry
1
2016
1738
0.090
 Why?
Brain
2
2020
2668
0.090
 Why?
Immunosuppressive Agents
1
2016
890
0.090
 Why?
Cisplatin
1
2013
320
0.090
 Why?
Triple Negative Breast Neoplasms
1
2014
202
0.090
 Why?
Immunotherapy
1
2015
641
0.090
 Why?
Models, Biological
1
2018
1783
0.090
 Why?
Contrast Media
1
2013
467
0.080
 Why?
Patient Compliance
1
2013
581
0.080
 Why?
Polymorphism, Single Nucleotide
1
2016
2189
0.080
 Why?
Dose-Response Relationship, Radiation
2
2020
141
0.070
 Why?
Liver Neoplasms
1
2014
786
0.070
 Why?
Antibodies, Monoclonal, Murine-Derived
2
2019
86
0.070
 Why?
Prednisone
2
2019
240
0.070
 Why?
Cytarabine
2
2018
61
0.070
 Why?
Biomarkers, Tumor
1
2014
1276
0.070
 Why?
Colorectal Neoplasms
1
2014
806
0.060
 Why?
Proteoglycans
1
2007
107
0.060
 Why?
Integrins
1
2007
95
0.060
 Why?
Time Factors
4
2018
6828
0.060
 Why?
Practice Guidelines as Topic
1
2014
1587
0.060
 Why?
Treatment Failure
2
2018
356
0.060
 Why?
Glycine
1
2006
176
0.060
 Why?
Amino Acid Substitution
1
2006
307
0.060
 Why?
Clinical Decision-Making
2
2019
322
0.060
 Why?
Fertility Preservation
1
2025
49
0.060
 Why?
Neoplasm Invasiveness
2
2017
510
0.060
 Why?
X-ray Repair Cross Complementing Protein 1
1
2023
13
0.050
 Why?
Standard of Care
1
2024
72
0.050
 Why?
Intelligence Tests
1
2023
57
0.050
 Why?
X-Rays
1
2023
28
0.050
 Why?
Cell- and Tissue-Based Therapy
1
2024
81
0.050
 Why?
Regression Analysis
2
2016
1024
0.050
 Why?
Pregnancy
3
2025
6763
0.050
 Why?
Proto-Oncogene Proteins c-sis
1
2023
39
0.050
 Why?
Terminology as Topic
1
2024
216
0.050
 Why?
Inducible T-Cell Co-Stimulator Protein
1
2022
10
0.050
 Why?
Analysis of Variance
2
2016
1316
0.050
 Why?
Cytidine Deaminase
1
2023
61
0.050
 Why?
Phenotype
3
2021
3196
0.050
 Why?
Brain Stem
1
2023
94
0.050
 Why?
Ribose
1
2021
23
0.050
 Why?
Adenosine Diphosphate
1
2021
79
0.050
 Why?
Radiosurgery
1
2024
344
0.040
 Why?
Troponin T
1
2021
65
0.040
 Why?
Poly (ADP-Ribose) Polymerase-1
1
2021
50
0.040
 Why?
Feedback
1
2021
173
0.040
 Why?
Immunotherapy, Adoptive
1
2024
327
0.040
 Why?
Automation
1
2020
95
0.040
 Why?
Neoplasms, Radiation-Induced
1
2020
92
0.040
 Why?
Prevalence
2
2016
2734
0.040
 Why?
Risk Management
1
2020
93
0.040
 Why?
Infant
2
2025
9465
0.040
 Why?
Incidence
2
2016
2804
0.040
 Why?
Neoplasms, Second Primary
1
2020
118
0.040
 Why?
Neuropsychological Tests
1
2023
1023
0.040
 Why?
Workflow
1
2020
165
0.040
 Why?
Mesentery
1
2019
48
0.040
 Why?
Safety
1
2020
338
0.040
 Why?
Busulfan
1
2018
16
0.040
 Why?
Melphalan
1
2018
35
0.040
 Why?
Respiration
1
2019
199
0.040
 Why?
Carmustine
1
2018
50
0.040
 Why?
Inhalation
1
2017
29
0.030
 Why?
Cone-Beam Computed Tomography
1
2017
39
0.030
 Why?
Subacute Combined Degeneration
1
2017
1
0.030
 Why?
Breast
1
2018
151
0.030
 Why?
Time-to-Treatment
1
2019
205
0.030
 Why?
Photons
1
2017
70
0.030
 Why?
Organ Sparing Treatments
1
2017
34
0.030
 Why?
Phosphorylation
1
2021
1759
0.030
 Why?
Deoxycytidine
1
2018
179
0.030
 Why?
Injections, Spinal
1
2017
105
0.030
 Why?
New York
1
2016
126
0.030
 Why?
Lymph Nodes
1
2019
491
0.030
 Why?
Orbit
1
2017
70
0.030
 Why?
Homocysteine
1
2017
156
0.030
 Why?
Procarbazine
1
2015
9
0.030
 Why?
Transforming Growth Factor beta1
1
2016
165
0.030
 Why?
Observer Variation
1
2016
343
0.030
 Why?
Genetic Markers
1
2016
344
0.030
 Why?
Mutation
1
2007
3958
0.030
 Why?
Folic Acid
1
2017
186
0.030
 Why?
Texas
1
2016
244
0.030
 Why?
Animals
2
2021
36940
0.030
 Why?
Mitochondria
1
2021
948
0.030
 Why?
Secondary Prevention
1
2016
233
0.030
 Why?
Molecular Targeted Therapy
1
2018
411
0.030
 Why?
Pregnancy Outcome
1
2017
416
0.030
 Why?
Gastrointestinal Diseases
1
2016
209
0.030
 Why?
Diagnostic Imaging
1
2017
332
0.030
 Why?
Abortion, Induced
1
2016
105
0.030
 Why?
Drug Administration Schedule
1
2016
786
0.030
 Why?
Acute Disease
1
2016
1007
0.030
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
289
0.030
 Why?
Postpartum Period
1
2016
340
0.030
 Why?
Mastectomy
1
2014
137
0.030
 Why?
Multivariate Analysis
1
2016
1509
0.020
 Why?
Diagnosis, Differential
1
2017
1483
0.020
 Why?
CD4-Positive T-Lymphocytes
1
2018
1091
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2018
900
0.020
 Why?
Ultrasonography
1
2016
759
0.020
 Why?
Surveys and Questionnaires
1
2025
5778
0.020
 Why?
Medical Oncology
1
2014
289
0.020
 Why?
Ovariectomy
1
2012
152
0.020
 Why?
Comorbidity
1
2016
1622
0.020
 Why?
Severity of Illness Index
1
2019
2828
0.020
 Why?
Quality of Life
1
2021
2892
0.020
 Why?
Kidney
1
2017
1468
0.020
 Why?
Electronic Health Records
1
2017
1069
0.020
 Why?
Diet
1
2017
1278
0.020
 Why?
Reproducibility of Results
1
2016
3284
0.020
 Why?
Anti-Bacterial Agents
1
2019
1809
0.020
 Why?
Genetic Predisposition to Disease
1
2016
2426
0.020
 Why?
Electrophoresis
1
2006
32
0.020
 Why?
Case-Control Studies
1
2014
3556
0.020
 Why?
DNA Mutational Analysis
1
2007
399
0.020
 Why?
Databases, Genetic
1
2007
237
0.020
 Why?
Protein Structure, Tertiary
1
2007
861
0.010
 Why?
Collagen
1
2007
452
0.010
 Why?
Mice
1
2021
17787
0.010
 Why?
Binding Sites
1
2007
1303
0.010
 Why?
Protein Binding
1
2007
2224
0.010
 Why?
Cells, Cultured
1
2006
4193
0.010
 Why?
Milgrom's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (359) concept(s)
_
Co-Authors Expand Description
See all (39) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)